SCHEMBL29537006

SCHEMBL29537006

CNc1nc(C)c2cc(Br)c(NCCO)nc2n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNA2 P20248 4/20 0.40
▸ CDK2 P24941 4/20 0.40
▸ CCNA1 P78396 4/20 0.40
▸ MAPK1 P28482 3/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ GAA P10253 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ POLB P06746 1/20 0.36
▸ EGFR P00533 3/20 0.35
▸ KDM4E B2RXH2 4/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ LMNA P02545 1/20 0.35
▸ PIK3CA P42336 1/20 0.34
▸ HTT P42858 2/20 0.33
▸ GLA P06280 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ SLC2A1 P11166 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25223077 1.00 CCNA2 (0.40) CCNA2CDK2CCNA1MAPK1KMT2A
SCHEMBL27103103 0.77 FLT3 (0.39) CCNA2CDK2CCNA1MAPK1KMT2A
SCHEMBL30595898 0.73 PIK3CA (0.36) MAPK1GAAPOLBKDM4EALDH1A1
SCHEMBL25230887 0.73 PIK3CA (0.36) MAPK1GAAPOLBKDM4EALDH1A1
SCHEMBL25230025 0.73 FLT3 (0.40) CCNA2CDK2CCNA1MAPK1KMT2A
SCHEMBL29536830 0.73 FLT3 (0.40) CCNA2CDK2CCNA1MAPK1KMT2A
SCHEMBL25225986 0.67 FLT3 (0.39) CCNA2CDK2CCNA1MAPK1KMT2A
SCHEMBL30595895 0.67 FLT3 (0.39) CCNA2CDK2CCNA1MAPK1KMT2A
SCHEMBL27103106 0.65 PRKCH (0.35) EGFRPRKCHPRKCEPRKCQPRKCD
SCHEMBL25420854 0.64 KDM4E (0.41) MAPK1GAAPOLBEGFRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116710453-A Kinase inhibitors and uses thereof 璧辰医药技术股份有限公司 2023-09-05 — — CN disclosed
EP-4192582-A1 KINASE INHIBITORS AND USES THEREOF ABM Therapeutics Corporation (US) 2023-06-14 — — EP disclosed
WO-2022032071-A1 KINASE INHIBITORS AND USES THEREOF ABM THERAPEUTICS CORPORATION (US) 2022-02-10 — — WO disclosed
Send feedback